Quantitative traits of prion strains are enciphered in the conformation of the prion protein

被引:0
|
作者
Safar, J [1 ]
Cohen, FE [1 ]
Prusiner, SB [1 ]
机构
[1] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Variations in prions, which cause different disease phenotypes, are often referred to as strains. Strains replicate with a high degree of fidelity, which demands a mechanism that can account for this phenomenon. Prion strains differ by qualitative characteristics such as clinical symptoms, brain pathology, topology of accumulated PrPSc, and Western blot patterns of glycosylated or deglycosylated PrPSc. Since none of these qualitative features can directly explain quantitative strain traits such as incubation time or dose response, we analyzed conformational parameters of PrPSc and the rate of accumulation in different prion strains. Using the conformation-dependent immunoassay (CDI), we were able to discriminate among PrPSc molecules from eight different prion strains propagated in Syrian hamsters. CDI quantifies PrP isoforms by simultaneously following antibody binding to both the denatured and native forms of a protein. In a plot of the ratio of antibody binding to denatured/native PrP graphed as a function of the concentration of PrPSc, each strain occupied a unique position, indicating that each strain accumulated different concentrations of particular PrPSc conformers. This conclusion was supported by a unique pattern of equilibrium unfolding of PrPSc found within each strain. By comparing the PrPSc levels before and after limited proteinase K digestion, we found that each strain produces a substantial fraction of protease-sensitive PrPSc. We asked whether this fraction of PrPSc might reflect those PrPSc molecules that are most readily cleared by cellular proteases. When the protease-sensitive PrPSc fraction was plotted as a function of the incubation time, a linear relationship was found with an excellent correlation coefficient (r = 0.94). Combined with the data on time courses of prion infection in Tg(MHu2M) and Tg(SHaPrP) mice, the results argue that different incubation times of various prion strains may arise predominantly from distinct rates of PrPSc clearance rather than from different rates of PrPSc formation.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [31] Prion protein scrapie and the normal cellular prion protein
    Atkinson, Caroline J.
    Zhang, Kai
    Munn, Alan L.
    Wiegmans, Adrian
    Wei, Ming Q.
    PRION, 2016, 10 (01) : 63 - 82
  • [32] Metabolism of minor isoforms of prion proteins Cytosolic prion protein and transmembrane prion protein
    Zhiqi Song
    Deming Zhao
    Lifeng Yang
    Neural Regeneration Research, 2013, 8 (30) : 2868 - 2878
  • [33] Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation
    Norstrom, Eric M.
    Ciaccio, Mark F.
    Rassbach, Benjamin
    Wollmann, Robert
    Mastrianni, James A.
    JOURNAL OF VIROLOGY, 2007, 81 (06) : 2831 - 2837
  • [34] Detecting Differences in Prion Protein Conformation by Quantifying Methionine Oxidation
    Silva, Christopher J.
    Erickson-Beltran, Melissa
    ACS OMEGA, 2022, 7 (03): : 2649 - 2660
  • [35] Common Structural Traits across Pathogenic Mutants of the Human Prion Protein and Their Implications for Familial Prion Diseases
    Rossetti, Giulia
    Cong, Xiaojing
    Caliandro, Rocco
    Legname, Giuseppe
    Carloni, Paolo
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 411 (03) : 700 - 712
  • [36] Differential impact of variations in prion protein (PrP) primary structure on susceptibility to different scrapie prion strains
    Scott, MR
    Groth, D
    Prusiner, SB
    NEUROLOGY, 1996, 46 (02) : 3086 - 3086
  • [37] Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles
    Agrimi, Umberto
    Nonno, Romolo
    Dell'Omo, Giacomo
    Di Bari, Michele Angelo
    Conte, Michela
    Chiappini, Barbara
    Esposito, Elena
    Di Guardo, Giovanni
    Windl, Otto
    Vaccari, Gabriele
    Lipp, Hans-Peter
    PLOS PATHOGENS, 2008, 4 (07)
  • [38] Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
    Minikel, Eric Vallabh
    Zhao, Hien T.
    Le, Jason
    O'Moore, Jill
    Pitstick, Rose
    Graffam, Samantha
    Carlson, George A.
    Kavanaugh, Michael P.
    Kriz, Jasna
    Kim, Jae Beom
    Ma, Jiyan
    Wille, Holger
    Aiken, Judd
    McKenzie, Deborah
    Doh-Ura, Katsumi
    Beck, Matthew
    O'Keefe, Rhonda
    Stathopoulos, Jacquelyn
    Caron, Tyler
    Schreiber, Stuart L.
    Carroll, Jeffrey B.
    Kordasiewicz, Holly B.
    Cabin, Deborah E.
    Vallabh, Sonia M.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (19) : 10615 - 10631
  • [39] Conformational conversion of prion protein in prion diseases
    Zhou, Zheng
    Xiao, Gengfu
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2013, 45 (06) : 465 - 476
  • [40] The cellular prion protein beyond prion diseases
    Manni, Giorgia
    Lewis, Victoria
    Senesi, Matteo
    Spagnolli, Giovanni
    Fallarino, Francesca
    Collins, Steven J.
    Mouillet-Richard, Sophie
    Biasini, Emiliano
    SWISS MEDICAL WEEKLY, 2020, 150